Enacted — Signed by the President — Jun 29, 2015
Last Action: Signed by President.
Explanation: This bill was enacted after being signed by the President on June 29, 2015.
Nov 6, 1997
105th Congress, 1997–1998
This bill was introduced on November 6, 1997, in a previous session of Congress, but was not enacted.
Representative for Connecticut's 1st congressional district
Read Text »
Last Updated: Nov 6, 1997
Length: 3 pages
The “H.R.” in “H.R. 2851” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B .... Retrieved from https://www.govtrack.us/congress/bills/105/hr2851
“H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B ....” www.GovTrack.us. 1997. July 4, 2015 <https://www.govtrack.us/congress/bills/105/hr2851>
|title=H.R. 2851 (105th)
|accessdate=July 4, 2015
|author=105th Congress (1997)
|date=November 6, 1997
|quote=To prohibit application of a payment limit to a drug or biological under part B ...